|
Board of Directors
- James
C. Mullen
Chairman and Chief Executive Officer, Biogen Inc.
- Alan Belzer
President, Chief Operating Officer and Director, Allied-Signal,
Inc. (retired)
- Lawrence C. Best
Senior Vice President and Chief Financial Officer, Boston Scientific
- Thomas F. Keller, Ph.D.
R.J. Reynolds Professor and Former Dean, Fuqua School of Business,
Duke University
- Mary L. Good, Ph.D.
Former Undersecretary for Technology, U.S. Department of Commerce
- Roger H. Morley
Vice President, Schiller International University
- Sir Kenneth Murray, Ph.D.
Biogen Professor of Molecular Biology, University of Edinburgh;
Fellow of The Royal Society
- Eckhard Pfeiffer
Former Compaq President and Chief Executive Officer
- Phillip A. Sharp, Ph.D.
Director of the McGovern Institute for Brain Research, Massachusetts
Institute of Technology; Nobel Laureate
- Alan K. Simpson
Visiting Lecturer, University of Wyoming
- James W. Stevens
Former Chairman, Prudential Asset Management Group
Sir Kenneth Murray, Ph.D.
Biogen Professor of Molecular Biology, University of Edinburgh;
Fellow of The Royal Society
Director since 1980; Biogen Professor of Molecular Biology, University of Edinburgh, Scotland since 1984 (Emeritus since 1998); during 1985 and 1986, Interim Research Director of Biogen S.A.; Fellow of the Royal Society.
|
|
